Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-09-25T00:15:59.198Z.
Calculation as of: 2026-09-25T00:15:59.198Z.
Quote observation: 2026-09-24T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d36a9ef3dd00a3b0176393925906ed0ad09061a29621a98fe511a29c7f47a262
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Market Cap
$31.49B
Operating Cash Flow Yield
7.23%
TTM Avg
5.95%
3Y Avg
4.74%
5Y Avg
4.24%
Market Cap
$33.01B
Operating Cash Flow Yield
5.30%
TTM Avg
5.37%
3Y Avg
3.37%
5Y Avg
2.54%
Market Cap
$33.40B
Operating Cash Flow Yield
1.90%
TTM Avg
1.24%
3Y Avg
0.80%
5Y Avg
0.80%
Market Cap
$33.45B
Operating Cash Flow Yield
8.61%
TTM Avg
9.07%
3Y Avg
8.37%
5Y Avg
7.76%
Market Cap
$30.70B
Operating Cash Flow Yield
3.18%
TTM Avg
3.55%
3Y Avg
3.64%
5Y Avg
3.31%
Market Cap
$30.58B
Operating Cash Flow Yield
31.93%
TTM Avg
22.49%
3Y Avg
14.32%
5Y Avg
14.96%
Market Cap
$29.98B
Operating Cash Flow Yield
4.73%
TTM Avg
5.73%
3Y Avg
5.66%
5Y Avg
5.62%
Market Cap
$29.48B
Operating Cash Flow Yield
9.79%
TTM Avg
6.35%
3Y Avg
4.36%
5Y Avg
3.61%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ResMed Inc. (RMD) | $32.19B | N/A | N/A | N/A | N/A |
| Alcon Inc. (ALC)vs › | $31.49B | 7.23% | 5.95% | 4.74% | 4.24% |
| DexCom, Inc. (DXCM)vs › | $33.01B | 5.30% | 5.37% | 3.37% | 2.54% |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $33.40B | 1.90% | 1.24% | 0.80% | 0.80% |
| Biogen Inc. (BIIB)vs › | $33.45B | 8.61% | 9.07% | 8.37% | 7.76% |
| Mettler-Toledo International Inc. (MTD)vs › | $30.70B | 3.18% | 3.55% | 3.64% | 3.31% |
| Centene Corp. (CNC)vs › | $30.58B | 31.93% | 22.49% | 14.32% | 14.96% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $29.98B | 4.73% | 5.73% | 5.66% | 5.62% |
| Zoetis Inc. (ZTS)vs › | $29.48B | 9.79% | 6.35% | 4.36% | 3.61% |
| Medline Inc. (MDLN)vs › | $29.31B | 6.80% | 5.19% | 5.19% | 5.19% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
